FibroGen Inc (NASDAQ: FGEN) kicked off on Monday, up 3.34% from the previous trading day, before settling in for the closing price of $0.37. Over the past 52 weeks, FGEN has traded in a range of $0.33-$2.93.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -2.51%. While this was happening, its average annual earnings per share was recorded 65.07%. With a float of $93.27 million, this company’s outstanding shares have now reached $98.77 million.
Let’s determine the extent of company efficiency that accounts for 486 employees. In terms of profitability, gross margin is 76.65%, operating margin of -91.86%, and the pretax margin is -98.64%.
FibroGen Inc (FGEN) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of FibroGen Inc is 7.10%, while institutional ownership is 56.39%. The most recent insider transaction that took place on Jun 12 ’24, was worth 25,884. In this transaction Chief Medical Officer of this company bought 22,123 shares at a rate of $1.17, taking the stock ownership to the 82,123 shares. Before that another transaction happened on Mar 07 ’24, when Company’s CEO bought 50,000 for $1.91, making the entire transaction worth $95,470. This insider now owns 470,178 shares in total.
FibroGen Inc (FGEN) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 65.07% per share during the next fiscal year.
FibroGen Inc (NASDAQ: FGEN) Trading Performance Indicators
Take a look at FibroGen Inc’s (FGEN) current performance indicators. Last quarter, stock had a quick ratio of 1.24. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.22.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.71, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach -0.69 in one year’s time.
Technical Analysis of FibroGen Inc (FGEN)
Looking closely at FibroGen Inc (NASDAQ: FGEN), its last 5-days average volume was 1.59 million, which is a drop from its year-to-date volume of 2.63 million. As of the previous 9 days, the stock’s Stochastic %D was 10.20%. Additionally, its Average True Range was 0.09.
During the past 100 days, FibroGen Inc’s (FGEN) raw stochastic average was set at 1.07%, which indicates a significant decrease from 10.04% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 263.80% in the past 14 days, which was higher than the 151.73% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8702, while its 200-day Moving Average is $1.1710. However, in the short run, FibroGen Inc’s stock first resistance to watch stands at $0.3859. Second resistance stands at $0.3940. The third major resistance level sits at $0.4031. If the price goes on to break the first support level at $0.3687, it is likely to go to the next support level at $0.3596. Should the price break the second support level, the third support level stands at $0.3515.
FibroGen Inc (NASDAQ: FGEN) Key Stats
The company with the Market Capitalisation of 37.92 million has total of 99,474K Shares Outstanding. Its annual sales at the moment are 147,750 K in contrast with the sum of -284,230 K annual income. Company’s last quarter sales were recorded 50,640 K and last quarter income was -15,540 K.
